Yongwei Yu

6PUBLICATIONS
11CO-AUTHORS
Aircraft performance and flight control systemsRespiratory diseasesMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 14, 2026
Comparative Prognostic Performance of SOFA2.0 and SOFA for 28-Day Mortality in Patients Developing Sepsis During ECMO Support.

|Mar 16, 2026
Prolonged Thromboelastography R Time and Thrombocytopenia as Early Warning Indicators of Bleeding in ECMO Patients Who Developed Sepsis During Support: A Retrospective Cohort Study.

Mi Xu, Hao Xu, Yong-Wei Yu

|Dec 30, 2024
Pharmacokinetic Changes and Influencing Factors of Polymyxin B in Different ECMO Modes.

Mi Xu, Na Chen, Yong-Wei Yu

|Oct 11, 2024
Association Between Cerebral Microbleeds and Neurological Outcomes in Patients Who Underwent Extracorporeal Membrane Oxygenation.

Zhipeng Xu, Jingchen Zhang, Xing Fang

|May 22, 2024
Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.

Zhi-Hui Lin, Hua-Qiang Xiang, Yong-Wei Yu

|Jul 07, 2022
Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer.

Ya-Juan Wang, Man Liu, Hui-Ying Jiang

Pageof 1

Frequent Collaborators

1 joint publications

Zhi-Hui Lin

1 joint publications

Hua-Qiang Xiang

1 joint publications

Yang-Jing Xue

1 joint publications

Chang Wu